Patent Law Weblog
Month: May 2015
-
May 19, 2015 – "Best Practices for Cost-Effective Filing of PCT and EPO Patent Applications" (Technology Transfer Tactics) – 1:00 to 2:00 pm (Eastern) May 19-21, 2015 – EU Pharmaceutical Law Forum*** (Informa Life Sciences) – Brussels, Belgium May 20, 2015 – "Never Been a Better Time (For IP) Than Right Now?" (Intellectual Property Owners…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "USPTO and Plain Meaning of Terms" on May 21, 2015 beginning at 2:00 pm (ET). Brenton Babcock, Knobbe of Martens, Olson & Bear, LLP; Gary Ganzi of Evoqua Water Technologies LLC; and Joseph Weiss of the U.S. Patent & Trademark Office will discuss…
-
The American Bar Association (ABA) Center for Professional Development, Section of Intellectual Property Law, Section of International Law, and Young Lawyers Division will be offering a live webinar entitled "The New EU Unitary Patent & Unified Patent Court: Strategic Considerations for US Applicants/Patentees" on May 28, 2015 from 1:00 to 2:30 pm (ET). Margaret M.…
-
The Knowledge Group will offer a live webcast entitled "Patent Term Adjustment: 2015 Final Rules" on May 27, 2015 from 3:00 to 5:00 pm (ET). Mark Thronson of Dickstein Shapiro LLP; Robert Irani of Bennett Jones; and John C. Donch, Jr. of Volpe and Koenig, PC will review and discuss the nuances and changes in…
-
Morrison & Foerster LLP will be offering a webinar entitled "Inter Partes Review Strategy and Trends in the Life Sciences Industry: Implications for Patent Prosecutors and Litigators" on May 28, 2015 from 8:30 to 10:00 am (PDT). Tina E. Hulse, Administrative Patent Judge, Silicon Valley U.S. Patent Trademark Office; and Michael Jacobs, Matthew Kreeger, and…
-
By Andrew Williams — The Hatch Waxman statute created a safe-harbor provision, found at 35 U.S.C. § 271(e)(1), that allows ANDA filers and others to practice patented inventions without fear of infringement liability, provided the acts are "solely for uses reasonably related to the development and submission of information" to the FDA. Even though the…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Galderma Laboratories LP et al. v. Glenmark Generics Inc USA3:15-cv-01416; filed May 6, 2015 in the Northern District of Texas • Plaintiffs: Galderma Laboratories LP; Galderma SA; Galderma Research & Development SNC• Defendant: Glenmark…
-
By Kevin E. Noonan — One of the promises of the Human Genome Project was that knowledge of the entirety of the human genetic complement would permit researchers to identify genetic bases for diseases that had been intractable to conventional approaches. While these efforts have borne equivocal fruit much more slowly that expected or hoped,…
-
By Kevin E. Noonan — About three years ago, and less than two years after Congress passed and President Obama signed the Biologics Price Competition and Innovation Act (BPCIA) into law, the U.S. Food and Drug Administration issued a series of draft Guidances indicating how it was considering implementing the biosimilar approval pathway contained in…
-
By Donald Zuhn — A group of Senators led by Sen. Lamar Alexander (R-TN), the Chairman of the Senate Committee on Health, Education, Labor, and Pensions, sent a letter last month to Dr. Stephen Ostroff, the Acting Commissioner of the U.S. Food and Drug Administration, "to express concern and raise questions over how the Food…
Patent Docs 